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Summary
The present study was conducted to evaluate the antioxidant and 
anti-inflammatory activities of crude methanolic extract of Abe-
liophyllum distichum Nakai, and those of its partitioned fractions, 
including hexane, ethyl acetate, n-butanol, and aqueous. The anti- 
oxidant activities were analyzed by DPPH free radical scavenging 
and oxygen radical antioxidant capacity assay. Results showed that 
the BuOH fraction possessed a strong antioxidant activity through 
a hydrogen atom transfer reaction-based mechanism and a single 
electron transfer reaction-based mechanism. In lipopolysaccharide 
(LPS)-stimulated RAW 264.7 cells, the BuOH fraction of A. disti-
chum methanol extract exhibited a strong inhibitory effect on the 
nitric oxide production and inhibited the expression of pro-inflam-
matory mediators, including COX-2, TNF-α, and IL-6, through 
the inhibition of the MEK/ERK signaling pathway. In addition, 
the BuOH fraction inhibited the LPS-induced ROS level through 
the NADPH oxidase-independent mechanism. Furthermore, HPLC 
analysis identified chlorogenic acid, caffeic acid, gentisic acid, rutin, 
ferulic acid, and quercetin, and suggested that the antioxidant and 
anti-inflammatory activities of the BuOH fraction should be medi-
ated by the presence of higher amounts of caffeic acid, rutin, and 
ferulic acid than other fractions. Taken together, these results suggest 
that A. distichum extract is a source of antioxidant and anti-inflam-
matory compounds, and could be developed as a potential source for 
functional food and dietary health supplement.
Introduction
Inflammation is a pervasive form of defense process that evolved in 
organisms to protect themselves from injury, infection, and expo-
sure to contaminants (ASHLEY et al., 2012). Inflammatory diseases 
such as asthma, arthritis, vascular diseases, and cancer caused by 
excessive inflammation have become one of the major health issues. 
Macrophages are large white blood cells that play a critical role in 
the initiation, maintenance, and resolution of inflammation (FUJI- 
WARA and KOBAYASHI, 2005) and can be activated by cytokines 
(interferon gamma, granulocyte-monocyte colony stimulating factor, 
and tumor necrosis factor alpha), extracellular matrix proteins, bac-
terial endotoxins such as lipopolysaccharide (LPS), and other chemi-
cal mediators (FUJIWARA and KOBAYASHI, 2005). LPS, an endotoxin 
and a constituent of the outer membrane of gram-negative bacteria, 
stimulates innate immunity and results in the production of many 
inflammatory mediators, including nitric oxide (NO), tumor necrosis 
factor-alpha (TNF-α), interleukin-6 (IL-6), prostanoids, and leuko-
trienes (GILLESPIE et al., 2007; LEE et al., 2003). Inflammatory me-
diators were produced by the activation of the nuclear factor kappa 
B (NF-κB) and mitogen-activated protein kinase (MAPK) cascades 
in macrophages (CHUN et al., 2012). Therefore, LPS-induced inflam-
matory responses are suggested to be mediated by the activation of 
the NF-κB and MAPK signaling pathway. LPS also increases the 
intracellular reactive oxygen species (ROS) through the activation of 
NADPH oxidases and mitochondria respiratory chain systems, thus 
indicating that ROS regulates inflammatory diseases (EMRE et al., 
2007).
ROS, the modulator of redox-sensitive signaling, contribute to the 
innate immune response to resist various pathogens. However, an 
excessive amount of ROS caused by an imbalance between their 
cellular generation and antioxidant mechanisms can induce pro-
gressive oxidative damage to cellular components (i.e., lipids, mem- 
branes, proteins, and nucleic acids), resulting in the induction of 
cell death (SCHIEBER and CHANDEL, 2014). The most important 
source of ROS is the NADPH oxidase (NOX) family in the plasma 
membrane and mitochondria (BEDARD and KRAUSE, 2007). 
Although NOX-induced ROS are essential modulators of MAPK 
signaling pathways, which play a major role in cell physiology such 
as cell growth, proliferation, differentiation, and immune responses 
(MANEA et al., 2015), the NOX inhibitor has been shown to prevent 
the NF-κB-dependent inducible NO synthase (iNOS) expression 
and NO production in LPS-stimulated RAW264.7 cells (BAI et al., 
2005). In addition, the suppression of LPS-induced ROS production 
in mitochondria results in the reduction of LPS-induced MAPK 
activation and pro-inflammatory mediator production (PARK et al., 
2015). Therefore, the increased intracellular ROS activate ROS- 
sensitive signaling pathways that lead to the induction of inflamma-
tion (LIU et al., 2014b), suggesting that the therapeutic targeting of 
oxidative stress with antioxidant should be beneficial to improve 
inflammatory diseases.
Abeliophyllum distichum Nakai, commonly called white forsythia, 
is a monotypic genus with a single species of deciduous shrub in 
the olive family, Oleaceae, and is native to the south and central 
areas of Korea (OH et al., 2003). Although A. distichum has been 
used as a landscape plant, the pharmaceutical properties of A. disti-
chum, such as anti-cancer activity (Park et al., 2014), anti-diabetic 
activity through the inhibition of aldose reductase (Li et al., 2013), 
and antihypertensive activity (OH et al., 2003), have been recently 
revealed. In addition, biologically active compounds, including ac-
teoside, eutigoside B, isoacteoside, rutin, hirsutrin, and cornoside, 
have been isolated from this plant. These findings indicate that A. 
distichum has potential as a crude drug and a dietary health supple-
ment. However, extensive biological studies and the elucidation of 
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the underlying molecular mechanisms of action should be required 
for using this plant as a beneficial material for the food and pharma-
ceutical industries.
In this study, methanolic extract and its fractions were submitted to 
bioactivity evaluation by analyzing anti-oxidant and anti-inflamma-
tory activities. In addition, the investigation of the underlying intra-
cellular mechanisms of action suggested that the anti-inflammatory 
activity of A. distichum extract is mediated by the suppression of 
ROS-sensitive signaling pathways, including extracellular signal re-
gulated kinase (ERK) in LPS-stimulated RAW 264.7 cells. Further-
more, phenolic compounds were analyzed using high-performance 
liquid chromatography (HPLC) to determine the existence of various 
active phenolic compounds.
Material and methods
Materials
A. distichum methanolic extract (GNEP-AD-001; AD01) and its 
fractions [hexane fraction (GNEP-AD-002; AD02), ethyl acetate 
fraction (GNEP-AD-003; AD03), n-butanol fraction (GNEP-AD- 
004; AD04), and aqueous fraction (GNEP-AD-005; AD05)] were 
obtained from the Nature Environment Research Park of Gang-
won Province, South Korea. Bacterial LPS from Escherichia coli 
0127, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT), Griess reagent, and sodium nitrite were purchased from 
Sigma-Aldrich. Antibodies including MEK1/2, phospho-MEK1/2 
(Ser217/221), ERK1/2, phospho-ERK1/2 (Thr202/Tyr204), p38 
MAPK, and phospho-p38 MAPK (Thr180/Tyr182) were purchased 
from Cell Signalling Technology. iNOS and β-actin were obtained 
from Santa Cruz Biotechnology. Dulbecco’s modified Eagle’s me-
dium (DMEM), fetal bovine serum (FBS), penicillin, and strepto-
mycin were obtained from GE Healthcare Life Sciences. All other 
chemicals were obtained from Sigma-Aldrich.
DPPH radical scavenging activity
The free radical scavenging activity of methanolic extract and its 
fractions was analyzed using 1,1-diphenyl-2-picrylhydrazyl (DPPH). 
A total of 180 μl of freshly prepared DPPH solution (0.4 mM in 
80% MeOH) was plated in 96-well plates, and 20 μl of the sample 
(10 mg/ml) was added, followed by serial dilution to each well. Then, 
the plate was incubated for 10 min at room temperature in the dark 
condition. After 10 min, the absorbance values were measured at 
520 nm using an iMarkTM microplate reader (Bio-Rad). The RC50 
(50% reduction of DPPH radicals) was obtained from a graph of radi-
cal scavenging activity versus extract concentration. Butylated hy-
droxytoluene (BHT) was used as the standard.
Oxygen radical antioxidant capacity (ORAC) assay
A total of 150 μl of 0.08 μM fluorescein was mixed with 25 μl of 
phosphate buffer (blank), trolox (TE) standard (6.25 μM to 50 μM), or 
each concentration of extract in each well of a microplate. After incu-
bation at 37 °C for 10 min, 25 μl of fresh 2,2’-azobis(isobutyramidine) 
dihydrochloride (0.12 g/ml) added to each well. Fluorescence in-
tensity was measured every 1 min for 90 min using the SynergyTM 
HTX Multi-mode Microplate Reader (BioTek, Vermont, USA) with 
fluorescent filters (485 nm excitation and 530 nm emission). The net 
area under the fluorescein decay curve (AUC) was analyzed, and the 
ORAC values were calculated by comparing the AUC with the TE 
as a standard. 
Cell culture
The RAW 264.7 macrophage cell line was purchased from the Ko-
rea Cell Line Bank (Seoul, Korea). Cells were cultured in DMEM 
medium and supplemented with 10% FBS, 100 U/mL penicillin, and 
100 μg/ml streptomycin in an incubator containing humidified CO2 
(5%) at 37 °C.
Cell viability assay and determination of the NO level
Cell viability was measured with MTT reduction assay. RAW 264.7 
cells were plated at a density of 1.5×105 cells/ml in 96-well plates 
and incubated at 37 °C for 4 h. Then, the cells were treated in each 
concentration of extracts and stimulated with LPS (1 μg/ml). Af-
ter incubation for 24 h, 20 μl of MTT (5 mg/ml in PBS) solution 
was added to each well. Incubation was continued for 4 h more, the 
formazan crystals were dissolved in DMSO, and the optical density 
was measured at 520 nm using an iMARK microplate reader (Bio-
RAD). 
To analyze the NO level in the cultured medium, RAW264.7 cells 
were treated with or without LPS in the presence of extracts. After 
24 h, 100 μl of Griess reagent [1% sulfanilamide (w/v) and 0.1% (w/v) 
naphtylethylenediamine in 2.5% phosphoric acid (v/v)] was mixed 
with an equal volume of cell supernatant and incubated at room 
temperature for 10 min. The optical density at 540 nm was measu- 
red, and the NO concentration was calculated with reference to the 
standard curve generated using sodium nitrite.
Intracellular ROS measurement
Intracellular oxidative stress was detected using 2’,7’-dichlorofluo-
rescein diacetate (DCF-DA), as described by WARLETA et al. (2011). 
RAW 264.7 cells treated with or without LPS in the presence of ex-
tracts for 24 h were washed twice with Hank’s buffered salt solu-
tion (HBSS) and incubated with 20 μM of fresh DCFH-DA in HBSS 
for 30 min at 37 °C in a 5% CO2 incubator. Following washing with 
PBS, DCF fluorescence was measured at an excitation wavelength of 
485 nm and emission at 525 nm. The intracellular ROS level percent-
age was calculated as follows: 
F = [(A30 – A0)/A0] × 100,
where A0 is the fluorescence before incubation, and A30 is the fluo-
rescence after incubation for 30 min.
Western blotting
After treatment with extracts in the presence or absence of 1 μg/ml 
of LPS for 24 h, RAW 264.7 cells were analyzed by immunoblotting. 
The cells were washed three times with cold PBS and lysed in RIPA 
buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 
0.1% SDS, 0.5% sodium deoxylcholate, 1 mM EDTA, and 10 mM 
NaF). Then, 10 μg protein of each sample was separated by 10% 
SDS-polyacrylamide gels with electrophoresis and transferred to a 
PVDF membrane. After blocking nonspecific sites with 5% nonfat 
dried milk, the membranes were hybridized with specific antibodies. 
The signal was detected and visualized using a chemiluminescence 
system according to the manufacturer’s instructions. 
Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from RAW 264.7 cells treated with ex-
tracts in the presence or absence of 1 μg/ml of LPS using a TRI 
reagent (Molecular Research Center, Cincinnati, USA) and was 
reverse-transcribed into cDNA using the ReverTra Ace® qPCR RT 
Master Mix with qDNA Remover (TOYOBO, Co., Ltd, Osaka, Ja-
pan) in accordance with the manufacturer’s recommendations. qRT-
PCR was performed using the SYBR® Green Real-time PCR Master 
Mix (TOYOBO, Co., Ltd, Osaka, Japan) in the CFX96TM Real-time 
system (BIO-RAD) with default parameters. The expression level of 
each gene was normalized to β-actin. The specific primer pairs used 
in qRT-PCR are listed in Tab. S1.
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HPLC analysis
The HPLC system used was a Shimadzu liquid chromatography 
system (LC-10ADvp) using an ultraviolet-visible (UV-vis) detector 
(SPD-10A, Shimadzu, Japan) equipped with a UV-vis detector (SPD-
10A, Shimadzu, Japan) and Luna 5 μ C18(2) 100 A column (4.6 mm × 
250 mm, particle size 5 μm). The mobile phase consisted of solvents 
A and B. Solvent A was 0.1% trifluoroacetic acid in distilled water, 
and solvent B was 0.1% trifluoroacetic acid in acetonitrile. The gra- 
dient was 0-0.01 min, 90% A; 0.01-28 min, 60% A; 28-39 min, 40% 
A; 39-50 min, 10% A; 50-55 min, 10% A; 55-56 min, 90% A; and 
56-65 min, 90% A. Run time was 65 min using a flow rate of 0.7 ml/
min. The phenolic compounds were identified by the retention time 
of the standard measured from the peak area at 254 nm (chlorogenic 
acid and rutin), 280 nm (gentisic acid and quercetin), and 360 nm 
(caffeic acid and ferulic acid). The concentration was calculated by 
comparing the peak areas of the samples with the calibration curve 
of the standards.
Statistical analysis
All the experiments were conducted for three independent replicates, 
and data were expressed as mean ± standard deviation. The signifi-
cance of the between-group differences was determined by ANOVA 
and Duncan’s multiple range test. Differences at p < 0.05 were con-
sidered significant.
Results
Antioxidant activities of A. distichum methanolic extract and its 
fractions
To investigate the antioxidant activity of A. distichum, we initially 
analyzed the free radical scavenging activities of crude methano-
lic extract (AD01) and its fractions (AD02 to AD05). As shown in 
Fig. 1A, the highest free radical scavenging activity was recorded in 
AD04 (RC50 = 29.98 μg/ml), followed by the AD01 (RC50 = 61.82 
μg/ml), AD05 (RC50 = 106.64 μg/ml), AD03 (RC50 = 131.03 μg/
ml), and AD02 (RC50 = 183.73 μg/ml) fractions. In addition, AD04 
exhibited similar level of free radical scavenging activity to the posi-
tive control, BHT (RC50 = 33.81 μg/ml). 
The assays used to determine the total antioxidant activity can be 
divided into hydrogen atom transfer reactions (HAT)-based assays 
and single electron transfer reactions (SET)-based assays. The DPPH 
assay is based on both HAT and SET, and the ORAC assay is based 
on HAT (LIANG and KITTS, 2014). The ORAC assay is relevant in 
in vivo conditions because it provides peroxyl radicals, which are 
the most common free radical in human biology (PRIOR, 2015). 
Therefore, the ORAC assay is broadly applied in the nutraceutical, 
pharmaceutical, and food industries. To further characterize the 
antioxidant property of A. distichum, we analyzed the antioxidant 
capacity using the ORAC assay. As shown in Fig. 1B, the hydrophi-
lic oxygen radical scavenging activities of crude methanolic extract 
and its fractions were concentration dependent. AD01 and AD04 at 
50 μg/ml exhibited an ORAC value of 137.45 μM TE and 180.17 μM 
TE, respectively, and AD02 at 50 μg/ml displayed an ORAC value 
of 13.85 μM TE. Taken together, these results indicate that AD04 
possesses a stronger antioxidant activity than other fractions and that 
AD04 may be used as a suppressor of ROS-sensitive inflammatory 
signaling pathways. 
Effects of A. distichum methanolic extract and its fractions on 
NO production in LPS-stimulated RAW264.7 cells 
NO is an intercellular messenger that has many physiological func-
tions, including roles in the regulation of vascular relaxation, platelet 
aggregation, neurotransmission, cellular respiration, and immune 
responses (IBIZA and SERRADOR, 2008). Although NO has been re- 
cognized as an important component of the immune system, over-
production of NO under pathological conditions induces host tissue 
damage associated with acute and chronic inflammations (NAGY 
et al., 2007; TRIPATHI et al., 2007). Therefore, the inhibition of NO 
production under inflammatory stimuli is relevant in the develop-
ment of new drugs for the treatment of chronic inflammatory disea- 
ses. The ability of A. distichum methanolic extract and its fractions 
to modulate the production of NO was determined in LPS-stimulated 
RAW 264.7 cells. As shown in Fig. 2A, the cells treated with LPS 
alone exhibited a marked increase in NO release (52.9 μM nitrite) 
compared with the non-treated cells, whereas all tested samples 
exhibited the inhibitory effect on LPS-induced NO production in a 
dose-dependent manner. AD03 at 100 μg/ml inhibited NO produc-
tion (19 μM nitrite) by 35% over the level generated by LPS (Fig. 2A). 
Although AD04 exhibited a lower inhibitory effect on LPS-induced 
NO production than AD03, 100 μg/ml of AD04 significantly inhi- 
bited LPS-induced NO production (29.1 μM nitrite). 
To investigate whether these inhibitory effects on LPS-induced NO 
production were mediated by cell viability, the cytotoxic effect of 
A. distichum methanolic extract and its fractions on macrophages 
was determined by MTT assay (Fig. 2B). Incubation with AD03 
significantly inhibited the proliferation of LPS-stimulated RAW 
264.7 cells, and AD04 did not exhibit cytotoxic activity. This find-
ing indicates that the inhibitory effect of AD03 on NO production 
is attributed to cytotoxicity. Therefore, AD04 was used to further 
investigate the mechanisms underlying the anti-inflammatory effect 
of A. distichum.
Fig. 1:  Antioxidant activities of Abeliophyllum distichum extract. (A) 
DPPH radical scavenging activity of A. distichum methanol crude 
extract and its fractions. Bar graph showing the RC50 values for 
each extract from the DPPH assay. (B) ORAC values of A. distichum 
methanol crude extract and its fractions. Data are expressed as μM 
of Trolox (TE) equivalents. Data are expressed as the mean ± stan-
dard deviation of three independent experiments. Values in the same 
column with different superscripted letters are significantly diffe- 
rent (p < 0.05). MeOH extract; AD01, hexane fraction; AD02, ethyl 
acetate fraction; AD03, n-butanol fraction; AD04, aqueous fraction; 
AD05.
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Inhibition of LPS-induced iNOS by AD04 
To confirm the inhibitory effect on LPS-induced NO production, the 
inhibitory effect of different concentrations (25, 50, 100, and 200 μg/
ml) of AD04 was analyzed. As expected, AD04 inhibited the LPS-
induced NO production in a dose-dependent manner (Fig. 3A). In 
addition, all tested concentrations of AD04 did not affect cell viabi- 
lity regardless of the presence of LPS for 24 h (Fig. 3B). This result 
indicates that AD04 has the most potent anti-inflammatory property 
against LPS stimulation. 
NO is produced in endothelial cells by three distinct isoforms of 
nitric oxide synthases (NOS), namely, endothelium NO synthase 
(eNOS), neural NO synthase (nNOS), and iNOS (WINK et al., 2011). 
eNOS and nNOS are constitutively expressed, and iNOS is expressed 
only after cellular activation (MCADAM et al., 2012). Although NO is 
produced more rapidly by the eNOS or nNOS than by the iNOS path-
way, iNOS is considered to be capable of generating larger quantities 
of NO than eNOS or nNOS (NAGY et al., 2007). The large quantity of 
NO generated by iNOS is used as a defense mechanism. Therefore, 
the induction of iNOS is the direct consequence of the inflamma-
tory process (SUSCHEK et al., 2004). Based on the findings above, 
we investigated whether the inhibitory effect of AD04 on LPS-in-
duced NO production was related to the down-regulation of iNOS. 
As shown in Fig. 3C, stimulation with LPS strongly induced the ac-
cumulation of iNOS protein in RAW 264.7 cells compared with the 
unstimulated cells. In addition, the treatment of cells with AD04 sup-
pressed the LPS-induced iNOS protein. The level of iNOS is known 
to be regulated in both transcriptional and post-transcriptional (e.g., 
total protein synthesis and degradation of iNOS protein) mechanisms 
(CHIOU et al., 2000). In RAW 264.7 cells, LPS increased the endo- 
genous mRNA level of iNOS, whereas AD04 significantly sup-
pressed the LPS-induced iNOS expression (Fig. 3D). These results 
indicate that AD04 inhibits the LPS-induced NO production through 
the suppression of iNOS expression.
AD04 suppresses TNF-α, IL-6, and COX-2 expression through 
the inhibition of MAPK cascade activation in LPS-induced RAW 
264.7 cells
LPS is known as a strong inducer of proinflammatory cytokines, 
including IL-6, IL-1, and TNF-α involved in the up-regulation of 
inflammatory reactions (FROST et al., 2002). In addition, proinflam-
matory cytokines can induce cyclooxygenase-2 (COX-2), which 
is the important source of prostanoid formation in inflammation 
(RICCIOTTI and FITZGERALD, 2011). Therefore, proinflammatory 
cytokines have been used as predictive biomarkers of inflammatory 
diseases. To further investigate the anti-inflammatory effect of AD04 
Fig. 2:  Effects of A. distichum methanol crude extract and its fractions on 
NO production (A) and cell viability (B) in LPS-stimulated RAW 
264.7 cells. RAW264.7 cells were treated with or without LPS in the 
presence of A. distichum methanol crude extract and its fractions for 
24 h. The amounts of NO were determined using the Griess reagent 
in the culture medium, and cytotoxicity was determined by MTT 
assay. Values are the mean ± SD of triplicate experiments. * p < 
0.05, ** p < 0.01, and *** p < 0.001 represent the significant differ-
ences in comparison with the cells treated with LPS alone. MeOH 
extract; AD01, hexane fraction; AD02, ethyl acetate fraction; AD03, 
n-butanol fraction; AD04, aqueous fraction; AD05.
Fig. 3:  Anti-inflammatory effect of BuOH fraction (AD04). The effect of 
AD04 on NO production (A) and cell viability (B) in LPS-stimula- 
ted RAW 264.7 cells were analyzed. NO contents were analyzed by 
the Griess assay, and cytotoxicity was determined by MTT assay. 
LPS-stimulated RAW 264.7 cells were treated with different con-
centrations of AD04 for 24 h and subjected to Western blotting (C) 
and qRT-PCR (D) for iNOS. The transcript level of iNOS was nor-
malized to the constitutive expression level of β-actin and expressed 
relative to the values of LPS alone. β-actin was used as an internal 
control for Western blotting. Values in the same column with diffe- 
rent superscripted letters are significantly different (p < 0.05). 
Values are the mean ± SD of triplicate experiments. 
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on LPS-stimulated RAW 264.7 cells, we analyzed the transcription 
levels of TNF-α, IL-6, and COX-2. The significantly increased levels 
of TNF-α, IL-6, and COX-2 were observed in LPS-stimulated RAW 
264.7 cells, and these increases were inhibited by the treatment of 
AD04 (Fig. 4). Therefore, the anti-inflammatory property of A. disti-
chum is mediated by the down-regulation of LPS-induced proinflam-
matory cytokine production.
The MAPK signaling pathway is responsible for important intra-
cellular signaling cascades, which regulate cell proliferation, dif-
ferentiation, development, inflammatory responses, and apoptosis 
(KAMINSKA, 2005). In LPS-induced proinflammatory responses, the 
MAPK signaling pathway plays an important role in the production 
of proinflammatory cytokines and NO (TURNER et al., 2014), thus 
suggesting that the MAPK signaling pathway is a potential molecu-
lar target for anti-inflammatory therapy. To investigate the inhibitory 
effect of AD04 on the MAPK signaling pathway in LPS-stimulated 
RAW264.7 cells, the activation of MEK1/2, ERK1/2, and p38 was 
analyzed. As shown in Fig. 5, LPS stimulation strongly induced the 
activation of MAPK pathways, whereas AD04 inhibited the LPS-
induced phosphorylation of MEK1/2 and ERK1/2. In case of p38, 
LPS-induced activation was slightly or not inhibited by AD04, there-
by indicating that the suppression of LPS-induced TNF-α, IL-6, and 
COX-2 transcriptions was due to the inhibition of the MEK/ERK 
signaling pathway by AD04.
AD04 inhibits the LPS-induced ROS in RAW 264.7 cells
LPS has been characterized to induce the generation of ROS, which 
activates ROS-sensitive signaling pathways leading to the induction 
of inflammation. On the basis of this finding, we hypothesized that 
the inhibition of the LPS-induced MEK/ERK signaling pathway 
is due to the antioxidant activity of AD04, as shown in Fig. 1. To 
test this hypothesis, we analyzed the level of intracellular ROS us-
ing the fluorescent probe DCF-DA. When RAW 264.7 cells were 
treated with AD04, LPS-induced ROS was significantly suppressed 
in a dose-dependent manner (Fig. 6A). In addition, the expression 
of LPS-induced NOX-1 and NOX-2, which are known as major re-
sources of ROS in immune cells (BEDARD and KRAUSE, 2007), was 
inhibited by AD04 in a dose-independent manner (Fig. 6B and 6C). 
However, the Pearson correlation analysis revealed that the intracel-
lular ROS level was not correlated with the expression patterns of 
NOX-1(correlation coefficient R2 = 0.575) and NOX-2 (R2 = 0.584). 
We also analyzed whether AD04 affected the expression of gene 
involved in the antioxidant system, such as copper/zinc superoxide 
dismutase (Cu/Zn SOD) and catalase, in LPS-stimulated RAW 264.7 
cells. As shown in Fig. 6D and 6E, AD04 did not significantly in-
duce the expression of catalase compared to that in the LPS-treated 
control group. Similarly, the expression of Cu/Zn SOD, an important 
enzyme in cellular oxygen metabolism, was not changed by the treat-
ment of AD04 in LPS-stimulated RAW264.7 cells. These findings 
suggest that the suppression of LPS-induced ROS by A. distichum 
is most likely mediated through its ability to scavenge LPS-induced 
ROS rather than either the inhibition of ROS production or the en-
hancement of the antioxidant system.
Fig. 4:  Effect of BuOH fraction (AD04) on the expression of LPS-induced 
COX-2, TNF-α, and IL-6. Total RNA was isolated from RAW264.7 
cells treated with or without LPS in the presence of AD04. The ex-
pression levels for each gene in different samples were calculated 
relative to its expression in LPS-stimulated RAW 264.7 cells. Data 
are expressed as the mean ± SD of three independent experiments. 
Mean separation within columns by Duncan’s multiple range test is 
at the 0.05% level.
Fig. 5:  Effects of BuOH fraction (AD04) on the activation of the LPS-in-
duced MAPK signaling pathway. Immunoblotting was performed 
using the lysate from RAW264.7 cells treated with or without 
LPS in the presence of AD04. Blots were incubated with antibody 
anti-phospho-MEK1/2 (p-MEK1/2), anti-MEK1/2, anti-phospho-
ERK1/2 (p-ERK1/2), anti-ERK1/2, anti-phospho-p38 (p-p38), and 
p38. β-actin was used as a loading control.
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Quantification of polyphenolic compounds in A. distichum ex-
tract by HPLC
Polyphenolic compounds including flavonoids are widely distributed 
in the plant kingdom. As more than several thousand polyphenolic 
compounds have been identified, flavonoids have been demonstrated 
to be beneficial in human healthcare, such as protecting against oxi-
dative stress, cancer, cardiovascular diseases, nervous system-related 
syndromes, and inflammatory disorders (PANDEY and RIZVI, 2009; 
PÉREZ-CANO and CASTELL, 2016). This finding suggests that poly-
phenolic compounds are potential active compounds in A. distichum 
extract. To identify the active compound that exhibits anti-inflam-
matory effects mediated by the inhibition of ROS-sensitive signal-
ing pathways, polyphenolic compounds were identified and quanti-
fied in A. distichum methanolic extract and its fractions using HPLC 
analysis. Six polyphenolic compounds, including chlorogenic acid, 
caffeic acid, gentisic acid, rutin, ferulic acid, and quercetin, were 
identified in A. distichum extract (Tab. 1). The major compound was 
gentisic acid in various samples, but hexane contained chlorogenic 
acid as a major compound. Although most of the samples contained 
these six compounds, AD04 had the highest content of caffeic acid 
(13.54 μg/g of extract), gentisic acid (231.09 μg/g of extract), rutin 
(101.31 μg/g of extract), and ferulic acid (48.96 μg/g of extract). 
Among these compounds, caffeic acid, rutin, and ferulic acid have 
been reported to show multiple biological effects, such as anti-
bacterial, antioxidant, anti-inflammatory, and anticancer activities 
(SRINIVASAN et al., 2007; LIU et al., 2014a; AL-DHABI et al., 2015). 
Therefore, the antioxidant and anti-inflammatory activities of AD04 
should be mediated by these active polyphenolic compounds togeth-
er with phytochemicals, which were not identified in this study.
Discussion
As natural plants are used not only as food but also as sources of 
traditional medicine since ancient times, the raw materials of plants 
have become a rich source of structurally diverse substances, which 
potentially have a wide range of pharmacological activities. There-
fore, the screening and the investigation of the pharmaceutical pro- 
perties of natural plants have opened a new era of developing alter-
native or complementary therapies. In this study, we investigated the 
biological activities of A. distichum, which is a monotypic taxon of 
Oleaceae, and is endemic to Korea. 
Plant-derived antioxidants with reducing or radical-scavenging ca-
pacity have been used because of growing concerns about the long-
term safety of synthetic antioxidant agents (ATAWODI, 2005) and 
additional health benefits, including reducing the risk of developing 
cancer and neurodegenerative diseases, anti-inflammatory actions, 
and anti-ageing effect (ALFADDA and SALLAM, 2012; ROLEIRA et al., 
2015; SZYMANSKA et al., 2016). In the case of A. distichum, AD04 
exhibited a strong antioxidant activity in both the HAT and SET 
mechanisms (Fig. 1). In addition, the free radical scavenging effect 
of AD04 (RC50 = 29.98 μg/ml) appeared to be similar to that of BHT 
(RC50 = 33.81 μg/ml), thus suggesting that AD04 could be a useful 
source of natural antioxidant agents. Furthermore, the presence of 
higher amounts of caffeic acid, rutin, and ferulic acid than other frac-
tion (Tab. 1) indicates that the strong antioxidant property of AD04 is 
due to these polyphenolic compounds.
Several plant-derived antioxidants, including polyphenolic com-
pounds, have been demonstrated to suppress inflammation through 
their antioxidant activities, the regulation of cellular activities of 
inflammatory related cells, and the modulation of the production of 
proinflammatory molecules by controlling gene expression and en-
zyme activities (GARCÍA-LAFUENTE et al., 2009). In LPS-stimulated 
RAW 264.7 cells, AD04 inhibited the activation of the MEK/ERK 
signaling pathway (Fig. 5), thus resulting in the decreased NO pro-
duction (Fig. 3A) and the suppression of COX-2, TNF-α, and IL-6 
Fig. 6:  Effects of BuOH fraction (AD04) on the production of LPS-induced 
ROS in RAW264.7 cells. (A) The LPS-induced intracellular ROS 
level was analyzed using the fluorescent probe DCF-DA. LPS-
stimulated RAW 264.7 cells in the presence of AD04 were used to 
measure the mRNA levels of NOX-1 (B) and -2 (C) and those of Cu/
Zn SOD (D) and catalase (E) by qRT-PCR. The relative amounts of 
transcripts were normalized to the levels of β-actin within the same 
sample. The value for the LPS-stimulated cells was set to 1.0. The 
average of three independent experiments is shown, and the error 
bars indicate the SD. Mean separation within columns by Duncan’s 
multiple range test is p < 0.05.
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expressions (Fig. 4). Polyphenolic compounds, such as myricetin, 
quercetin, and procyanidin B2, have been shown to directly bind to 
MEK1 to inhibit MEK/ERK signaling (NGUYEN et al., 2004; LEE 
et al., 2007; KANG et al., 2008). Therefore, one possible explana-
tion for the anti-inflammatory property of AD04 may be that the 
polyphenolic compounds in AD04 directly regulate LPS-induced 
MEK/ERK signaling in macrophages. In addition, LPS-induced in-
tracellular ROS production was inhibited by the treatment of AD04 
(Fig. 6A). In response to LPS, ROS were produced by multiple 
mechanisms, including the induction and activation of NOX and 
mitochondria respiratory chain systems as well as the suppression 
of anti-oxidative enzymes (WANG et al., 2004; EMRE et al., 2007). 
NOX-dependent ROS generation contributes to the activation of 
ERK1/2 and c-Jun-N-terminal kinase (HSIEH et al., 2010), which are 
involved in the excessive production of LPS-induced proinflamma- 
tory cytokines (ZHANG et al., 2016). The treatment of AD04 caused 
the suppression of LPS-induced NOX-1 and -2 (Fig. 6B and 6C), 
thereby indicating that AD04 might be able to inhibit NOX-depen-
dent ROS generation through the inhibition of NOX transcription. 
However, the NOX expression did not correlate with the level of intra-
cellular ROS in AD04-treated RAW 264.7 cells (Fig. 6). Thus, other 
possible explanation is that the anti-inflammatory effect of AD04 is 
mediated by the suppression of LPS-induced intracellular ROS level 
through its antioxidant activities (Fig. 1), although analyzing the ef-
fect of AD04 on the release of LPS-induced mitochondrial ROS is 
required. Taken together, these findings indicate that the inhibition 
of ROS-sensitive signaling, that is the MEK/ERK signaling, by A. 
distichum extract results in the suppression of the LPS-induced in-
flammatory response.
In conclusion, the in vitro data obtained from this study demonstra- 
ted the antioxidant and anti-inflammatory activities of A. distichum. 
In LPS-stimulated RAW264.7 cells, AD04 attenuated the production 
of NO and modulated the expression of pro-inflammatory mediators, 
such as COX-2, TNF-α, and IL-6. In addition, the results clearly indi-
cate that the inhibitory action of AD04 is mediated by the inhibition 
of the MEK/ERK signaling pathway. Although further studies are 
required to identify the active compounds as potential anti-inflam-
matory compounds, the presence of notable antioxidant and anti-
inflammatory activities in AD04 indicates that A. distichum has the 
potential to become a crude drug and a dietary health supplement.
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Primer Sequences (5’-3’) 
iNOS-F TCCTACACCACACCAAAC 
iNOS-Rev CTCCAATCTCTGCCTATCC 
COX-2-F CCTCTGCGATGCTCTTCC 
COX-2-Rev TCACACTTATACTGGTCAAATCC 
TNF-α-F AGCACAGAAAGCATGATCCG 
TNF-α-Rev CTGATGAGAGGGAGGCCATT 
IL-6-F CCACTTCACAAGTCGGAGGCTTA 
IL-6-Rev GTGCATCATCGCTGTTCATACAATC 
NOX-1-F AAGTGGCTGTACTGGTTGG 
NOX-1-Rev GTGAGGAAGAGTCGGTAGTT 
NOX-2-F ACTTCTTGGGTCAGCACTGG 
NOX-2-Rev ATTCCTGTCCAGTTGTCTTCG 
Cu/Zn SOD-F CAGCATGGGTTCCACGTCCA 
Cu/Zn SOD-Rev CACATTGGCCACACCGTCCT 
Catalase-F AAGACAATGTCACTCAGGTGCGGA 
Catalase-Rev GGCAATGTTCTCACACAGGCGTTT 
β-actin-F CCCACTCCTAAGAGGAGGATG 
β-actin-Rev AGGGAGACCAAAGCCTTCAT 
 
	  
